Eleni D. Tzika

Current situation of mycotoxin contamination and co-occurrence in animal feed--focus on Europe.

Mycotoxins are secondary metabolites produced by fungi especially those belonging to the genus Aspergillus, Penicillum and Fusarium. Mycotoxin contamination can occur in all agricultural commodities in the field and/or during storage, if conditions are favourable to fungal growth. Regarding animal feed, five mycotoxins (aflatoxins, deoxynivalenol, zearalenone, fumonisins and ochratoxin A) are covered by EU legislation (regulation or recommendation). Transgressions of these limits are rarely observed in official monitoring programs. However, low level contamination by Fusarium toxins is very common (e.g., deoxynivalenol (DON) is typically found in more than 50% of the samples) and co-contamination is frequently observed. Multi-mycotoxin studies reported 75%–100% of the samples to contain more than one mycotoxin which could impact animal health at already low doses. Co-occurrence of mycotoxins is likely to arise for at least three different reasons (i) most fungi are able to simultaneously produce a number of mycotoxins, (ii) commodities can be contaminated by several fungi, and (iii) completed feed is made from various commodities. In the present paper, we reviewed the data published since 2004 concerning the contamination of animal feed with single or combinations of mycotoxins and highlighted the occurrence of these co-contaminations.

EFFECT OF AN INACTIVATED PARAPOXVIRUS BASED IMMUNOMODULATOR (BAYPAMUN) ON POST WEANING DIARRHOEA SYNDROME AND WASTING PIG SYNDROME OF PIGLETS

Post weaning diarrhoea syndrome (PWDS) and wasting pig syndrome (WPS) are two entities of the pig industry induced by stress factors occurring at the early weaning and further complicated by opportunistic pathogens. In the present paper we examine--through one pilot and one final trial--whether prevention of these two syndromes can be achieved in the field by immunomodulation of the pig e.g., by improving its non-specific immunological response. In both trials two groups of early weaned piglets were submitted to the treatments. In the pilot trial the first group received no treatment and served as controls and the animals of the second group were injected twice with an inactivated Parapoxvirus based immunomodulator (Baypamun, Bayer, Germany). In the final trial the first group of piglets received no treatment and served as a control group. The animals of the second group were injected twice with a freeze-dried immunomodulator (Baypamun). Piglets were compared with regard to the severity of PWS, mortality, growth performance parameters, and for the presence of pathogens in their faeces. The results have shown that Baypamun treated piglets performed significantly better than negative control piglets in all the parameters examined. It was concluded that stimulation of the non-specific immunity of piglets may be helpful in preventing the appearance of PWDS and WPS in the field.

The effect of a natural feed additive (Macleaya cordata), containing sanguinarine, on the performance and health status of weaning pigs

The aim of this study was to investigate the efficacy of Sangrovit(®) , a plant-derived feed additive, given throughout the nursery stage via feed at 15 ppm and 50 ppm, on the health status and performance of weaners against negative controls. In a 900-sow farrow-to-finish farm, a total of 864 piglets were divided into three groups: (i) negative controls (NC); (ii) Sang 15: same feed as NCs, plus 15 g Sangrovit(®) /t of feed; (iii) Sang 50: same feed as NCs plus 50 g Sangrovit(®) /t of feed. The results indicated that administration of 50 ppm(-) Sangrovit(®) had the most beneficial effects on growth performance in weaning pigs. Specifically there was increase of body weight and average daily gain, as well as reduction of feed conversion ratio. Blood analysis from the Sang groups and especially the Sang 50 group revealed low values of haptoglobin and serum amyloid A.

Clinical evaluation of intradermal vaccination against porcine enzootic pneumonia (Mycoplasma hyopneumoniae)

The aim of the present study was to investigate the efficacy of single-dose intradermal vaccination against Mycoplasma hyopneumoniae on a commercial swine unit. A total of 1051 healthy suckling piglets of 28±3 days of age were randomly assigned to one of three experimental groups: (a) intradermal: 346 piglets vaccinated intradermally (Porcilis M Hyo ID Once, Intervet SPAH), (b) intramuscular : 351 piglets vaccinated intramuscularly (Porcilis M1 Intervet SPAH) and (c) controls: 354 piglets injected with a placebo (adjuvant only). Performance parameters such as average daily weight gain (ADG), as well as health parameters and lung lesion scores were monitored from four weeks of age until slaughter. The improvement in ADG over the controls, during the finishing phase, was 27 g/day for the intradermal group and 17 g/day for the intramuscular group. Both intradermal and intramuscular vaccinations were effective in reducing clinical signs and lung lesions caused by M hyopneumoniae. Compared with the controls, approximately 10.4 per cent fewer clinical cases were diagnosed in the intradermal group, and 6 per cent fewer in the intramuscular group, during the finishing period. In conclusion, performance results were better in the vaccinated groups than in the control group, while intradermal vaccination afforded greater protection than intramuscular vaccination, especially with regard to morbidity, lung lesion and pleuritis scores.

Cross-Sectional Serosurvey and Risk Factors Associated with the Presence of Toxoplasma gondii Antibodies in Pigs in Greece

INTRODUCTION Toxoplasmosis is a worldwide reported zoonotic infection caused by the protozoon Toxoplasma gondii. Pigs may become infected by ingesting feed or water contaminated with cat faeces, by cannibalism, and/or by eating infected rodents. T. gondii infected edible tissues of pigs are a source of infection for humans. This study was undertaken to detect seropositivity of pigs against T. gondii and identify possible risk factors as well as to compare two serological methods. METHODS A total of 609 blood samples were collected from 10% of the sows from 65 pig farms located in mainland Greece. Information about the geographical location, size, and biosecurity level of the herd was recorded. Samples were tested for the presence of antibodies against T. gondii employing the indirect fluorescent antibody test and the enzyme-linked immunosorbent assay. RESULTS Twenty-six positive samples were detected (4.3%) in 17 out of the 65 farms tested (26.2%). The average seroprevalence in affected herds was 26.8% (95% confidence interval 21.0-32.6%). Among the categorical data evaluated, the biosecurity level (odds ratio 0.17, p < 0.01) and the geographical characteristics (odds ratio 13.55, p < 0.05) significantly affected the presence of toxoplasmosis in the herd. Toxoplasmosis was recorded in significantly higher percentages in mountainous farms as compared to lowlands (p < 0.05) and in those with poor biosecurity levels than in those with very good (p < 0.05). A very good agreement (κ = 0.958) was observed between the two serological methods. CONCLUSION The presence of antibodies in pigs is indirect information on the risk of the infection and an indication of the necessity of biosecurity measures to be taken in order to control infection at least in the areas at highest risk.

A feed additive containing Bacillus toyonensis (Toyocerin ® ) protects against enteric pathogens in postweaning piglets

This study evaluated the efficacy of a probiotic containing Bacillus toyonensis spores (Toyocerin®) in postweaning piglets against enteric pathogens.

Effects of early vaccination with a gonadotropin releasing factor analog-diphtheria toxoid conjugate on boar taint and growth performance of male pigs1

The aim of this study was to evaluate safety (in terms of detecting possible adverse clinical effects attributable to vaccination), efficacy, and effects on growth performance of a gonadotropin releasing factor analog-diphtheria toxoid conjugate (commercially distributed as Improvac; Zoetis, Zaventem, Belgium) in male pigs raised in a commercial Greek farm. A total of 1,230 male pigs was enrolled in 16 weekly batches and allocated to 3 groups: barrows (castrated on the next day after birth [study Day 0]), pigs vaccinated with the above-mentioned product, and intact boars. Vaccinated pigs were injected subcutaneously with 2 mL of the anti-gonadotropin releasing factor (GnRF) vaccine at 9 to 11 wk of age (60-78 d) and 15 to 17 wk of age (102-120 d) and slaughtered at 22 to 25 wk of age (152-176 d). No clinical abnormalities or adverse events attributable to vaccination occurred. Mean BW of vaccinated pigs was 6% greater compared with barrows at slaughter (P < 0.0001). The vaccinated pigs had greater ADG than barrows from castration to slaughter (8%). In detail, a lower ADG from first to second vaccination (-12%; P < 0.0001) and a 27% greater ADG from second vaccination to slaughter (P < 0.0001) were observed. The ADG of vaccinated pigs and intact boars was not significantly different throughout the study, except from first to second vaccination (boars greater; P = 0.0059) and second vaccination to slaughter (vaccinates greater; P = 0.0390). Feed conversion ratio of barrows was 11 and 8% greater compared with vaccinated pigs (P = 0.0005) and boars (P = 0.0062) from first to second vaccination but was 23 to 26% lower compared with vaccinated pigs (P < 0.0001) and intact boars (P < 0.0001) from first vaccination to slaughter and 7 to 9.5% lower from the second vaccination to slaughter (P = 0.0029 and P = 0.0003 for vaccinates and intact boars, respectively). At slaughter, the belly fat androstenone concentration of all vaccinated pigs and 64% of intact boars was below 200 ng/g. Belly fat skatole concentration was below 20 ng/g in samples from all groups. In conclusion, vaccination against GnRF using the GnRF analog-diphtheria toxoid conjugate tested did not induce adverse clinical effects, proved effective, and compared with physical castration, resulted in greater BW at slaughter and improved ADG and feed conversion ratio from first vaccination to slaughter.

Greek experience of the use of phytogenic feed additives in organic pig farming

1 Clinic of Medicine, Faculty of Veterinary Medicine, University of Thessaly, 43100, Karditsa, Greece. 2 Farm Animal Clinic, School of Veterinary Medicine, Aristotle University of Thessaloniki, Greece. 3 Department of Animal Production, Technological Educational Institute of Larissa, Greece. 4 Research Associate Technical Manager, PROVET, Vrago, Aspropyrgos, Attica Greece. 5 Department of Obstetrics and Reproduction, Faculty of Veterinary Science, University of Thessaly, Greece.

Efficacy of In-Feed Valnemulin Hydrochloride for the Treatment and Control of Ileitis in Weaning and Growing Pigs

Abstract Tzika, E.D., Papatsiros, V.G., Kyriakis, S.C., Alexopoulos, C., Lymberopoulos, A.G. and Kyriakis, C.S. 2009. Efficacy of in-feed valnemulin hydrochloride for the treatment and control of ileitis in weaning and growing pigs. J. Appl. Anim. Res., 35: 181–184. To evaluate effect of in-feed valnemulin hydrochloride on control of proliferative enteropathy in weaning and growing pigs, 288 weaned piglets from a farm with a previous history of ileitis outbreaks were divided in three groups. The first group served as negative control, the second one received 50 ppm in-feed valnemulin hydrochloride, while the third one received 100 ppm in-feed tylosin phosphate for 21 d. Valnemulin hydrochloride and tylosin showed an effect in reducing diarrhea due to ileitis and the prevalence of Lawsonia intracellularis in faecal samples at the end of the growing period. There was also a significant improvement of productive parameters (body weight, ADG, FCR). Conclusively, the administration of valnemulin hydrochloride via feed, at the inclusion level of 50 ppm and for 21 d, controls ileitis significantly in weaned and growing piglets.

Antimicrobial resistance and residues in the EU: current situation and possible countermeasures, emphasis on Campylobacter and Salmonella

This review gives an overview on the prevalence of antimicrobial resistance in the food chain in the European Union. The main emphasis is on two important food pathogens, Campylobacter spp. and Salmonella spp. Furthermore, antibiotic residues reported in food commodities in the EU during 2008-2012, as well as the current legal framework regarding antibiotic use in the EU are discussed. In addition, the review also presents alternatives for the antibiotic treatment of food of animal origin.